IP Library Granted Patent US 8,101,347
Granted Patent B2
US 8,101,347 · App. 12/355,614 · Granted Jan 24, 2012

Method and compositions for immunization with the

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,347
App. No.
12/355,614
Granted
Jan 24, 2012
Kind
B2
Abstract

A method of inhibiting, moderating or diagnosing Pseudomonas aeruginosa infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.

Claims (8)

1. A method of diagnosing Pseudomonas aeruginosa infection comprising:

(a) exposing a patient's sample to a nucleotide probe, wherein the probe hybridizes specifically to nucleotides between residues 626-1510 of SEQ ID NO:8 or nucleotides encoding amino acid residues 144-257 of SEQ ID NO: 7, and wherein the probe comprises a single nucleotide sequence consisting of at least forty contiguous nucleotides between residues 626-1510 of SEQ ID NO:8;

(b) detecting the hybridization via PCR or RT-PCR with two primers, wherein each primer consists of a single nucleotide sequence consisting of at least 25 continuous nucleotides between residues 626-1510 of SEQ ID NO:8; and

(c) correlating Pseudomonas aeruginosa infection with the presence of the hybridized probe.

2. A method of diagnosing Pseudomonas aeruginosa infection comprising:

(a) exposing a patient's sample to a nucleotide probe, wherein the probe hybridizes specifically to nucleotides between residues 626-1510 of SEQ ID NO:8 or nucleotides encoding amino acid residues 144-257 of SEQ ID NO: 7, and wherein the probe comprises a single nucleotide sequence consisting of at least forty contiguous nucleotides between residues 626-1510 of SEQ ID NO:8;

(b) detecting the hybridization via PCR or RT-PCR with a PCR primer consisting of a single nucleotide sequence consisting of at least 25 continuous nucleotides between residues 626-1510 of SEQ ID NO:8; and

(c) correlating Pseudomonas aeruginosa infection with the presence of the hybridized probe.

Assignments (7)
CONFIRMATORY LICENSE Recorded Oct 8, 2020
From: MEDICAL COLLEGE OF WISCONSIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 054032/0981 →
CORRECTIVE ASSIGNMENT TO CORRECT THE STATEMENT OF FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT PREVIOUSLY RECORDED ON REEL 000020 FRAME 20. ASSIGNOR(S) HEREBY CONFIRMS THE THIS INVENTION WAS MADE WITH US GOVERNMENT SUPPORT AWARDED BY NIH GRANT NUMBERS AI001289, AI031665, AND HL059239. Recorded Jan 2, 2019
From: MEDICAL COLLEGE OF WISCONSIN
To: MEDICAL COLLEGE OF WISCONSIN
Reel/Frame 047999/0920 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
SECURITY INTEREST Recorded Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
SECURITY INTEREST Recorded May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2010
From: FRANK, DARA W.; YAHR, TIMOTHY L.; FRITZ, ROBERT B.
To: MCW RESEARCH FOUNDATION, INC.
Reel/Frame 024102/0596 →